lascorbic acid 2 phosphate (TargetMol)
TargetMol is a verified supplier 
TargetMol manufactures this product 
94
Structured Review
TargetMol
lascorbic acid 2 phosphate
Lascorbic Acid 2 Phosphate, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lascorbic+acid/L-Ascorbic+acid+2-phosphate/pm41535924-58-34-37
Average 94 stars, based on 1 article reviews
Lascorbic Acid 2 Phosphate, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lascorbic+acid/L-Ascorbic+acid+2-phosphate/pm41535924-58-34-37
Average 94 stars, based on 1 article reviews
lascorbic acid 2 phosphate - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Recombinant:Article Title: Sympathetic-like-integrated engineered heart tissue models AGEs-induced adverse remodeling. Article Snippet: .. Cardiomyocyte (CM) differentiation was initiated using established protocols once cells reached ~90% confluence by switching to CDM3 [23,24], which contained RPMI 1640 (Gibco, USA), 500 μg/mL recombinant serum albumin (Aladdin, China), and 213 μg/mL Article Title: Integrating melt electrospinning writing and microfluidics to engineer a human cardiac microenvironment for high-fidelity drug screening Article Snippet: .. At this point, the growth medium was replaced with Cardiac Differentiation Medium 3 (CDM3), which was composed of RPMI 1640 medium, supplemented with 500 μg/ml of recombinant human serum albumin derived from Article Title: Integrating melt electrospinning writing and microfluidics to engineer a human cardiac microenvironment for high-fidelity drug screening Article Snippet: The preclinical evaluation of drug-induced cardiotoxicity is critical for developing novel drug, helping to avoid drug wastage and post-marketing withdrawal.. Although human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) and the engineered heart organoid have been used for drug screening and mimicking disease models, they are always limited by the immaturity and lack of functionality of the cardiomyocytes.. In this study, we constructed a Cardiomyocytes-on-a-Chip (CoC) that combines micro-grooves (MGs) and circulating mechanical stimulation to recapitulate the well-organized structure and stable beating of myocardial tissue. Article Title: Sympathetic-like-Integrated Engineered Heart Tissue Models AGEs-Induced Adverse Remodeling Article Snippet: .. Cardiomyocyte (CM) differentiation was initiated using established protocols once cells reached ~ 90% con uence by switching to CDM3 [21, 22], which contained RPMI 1640 (Gibco, USA), 500 μg/mL recombinant serum albumin (Aladdin, China), and 213 μg/mL L-ascorbic Article Title: Sympathetic-like-integrated engineered heart tissue models AGEs-induced adverse remodeling Article Snippet: .. Cardiomyocyte (CM) differentiation was initiated using established protocols once cells reached ~ 90% confluence by switching to CDM3 [ , ], which contained RPMI 1640 (Gibco, USA), 500 μg/mL recombinant serum albumin (Aladdin, China), and 213 μg/mL L-ascorbic Derivative Assay:Article Title: Integrating melt electrospinning writing and microfluidics to engineer a human cardiac microenvironment for high-fidelity drug screening Article Snippet: .. At this point, the growth medium was replaced with Cardiac Differentiation Medium 3 (CDM3), which was composed of RPMI 1640 medium, supplemented with 500 μg/ml of recombinant human serum albumin derived from Article Title: Integrating melt electrospinning writing and microfluidics to engineer a human cardiac microenvironment for high-fidelity drug screening Article Snippet: The preclinical evaluation of drug-induced cardiotoxicity is critical for developing novel drug, helping to avoid drug wastage and post-marketing withdrawal.. Although human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) and the engineered heart organoid have been used for drug screening and mimicking disease models, they are always limited by the immaturity and lack of functionality of the cardiomyocytes.. In this study, we constructed a Cardiomyocytes-on-a-Chip (CoC) that combines micro-grooves (MGs) and circulating mechanical stimulation to recapitulate the well-organized structure and stable beating of myocardial tissue. |